TFF PHARMACEUTICALS INC (TFFP)

US87241J2033 - Common Stock

2.03  -0.44 (-17.81%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
90K500K
455.56%		733.87K
46.77%		306K
-58.30%
EBITDA
YoY % growth
-31.68M
-69.50%		-31.41M
0.85%		-21.392M
31.89%		24.174M
213.00%
EBIT
YoY % growth
-31.79M
-70.09%		-31.8M
-0.03%		-21.895M
31.15%		-25.259M
-15.37%
Operating Margin
-35,322.22%-6,360.00%-2,983.45%-8,254.67%
EPS
YoY % growth
-1.25
-38.89%		-3.46
-176.80%		-12.51
-261.56%		-5.47
56.30%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-2.31
51.47%
Revenue
Q2Q % growth		76.5K
53.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.73M
19.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -2.01
19.60%		-2.160.157.05%
Q3 2023
Q2Q % growth		 -2.25
-675.86%		-2.930.6823.27%
Q2 2023
Q2Q % growth		 -3.50
-929.41%		-4.851.3427.76%
Q1 2023
Q2Q % growth		 -4.75
-1,339.39%		-5.871.1219.01%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 114.33K
-63.12%		102K12.33K12.09%
Q3 2023
Q2Q % growth		 234.76K
160.84%		51K183.76K360.31%
Q2 2023
Q2Q % growth		 330K
1,000.00%		68.003K261.997K385.27%
Q1 2023
Q2Q % growth		 50K
-28.57%		255K-205K-80.39%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-62.01% -62.01% -47.05% -1476.47%
Revenue-25% -25% -25% -25%